Profil Institute for Clinical Research to Continue Support of Insulindependence as Gold-Level Sponsor in 2012-2013
SAN DIEGO, April 17, 2012 /PRNewswire-iReach/ -- Insulindependence announced today that the Profil Institute for Clinical Research has re-signed as Gold-Level Sponsor in 2012-2013.
"We recognized early in our relationship that Insulindependence and Profil Institute are ideally aligned in our respective visions to revolutionize diabetes management," stated Peter Nerothin, Founder and President of Insulindependence.
Insulindependence provides unparalleled experiential diabetes education opportunities through a variety of recreation programs, uniting the diabetes community around a common desire to improve public health. Individuals of all ages and experiences are invited to participate in initiatives ranging youth mentoring to groundbreaking research.
Profil Institute's advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be the most highly regarded clinical research institute for early phase diabetes drug trials.
Insulindependence's community focus complements the scientific rigor and innovation for which Profil Institute is renowned. "We are grateful for Profil Institute's tireless pursuit of the best therapeutics and technologies for treating and managing diabetes. It is this combination of community stewardship and scientific expertise that makes our organization's partnership truly revolutionary," said Nerothin.
"As grateful as Insulindependence is of our support, we as a company are grateful to them for their untiring passion and enthusiasm in educating patients on diabetes management strategies and inspiring patients to set new personal fitness goals to improve their overall health," said Dr. Marcus Hompesch, CEO of Profil Institute. "We couldn't be more pleased to contribute our support to such an inspiring organization."
Insulindependence recognizes the significance of having an ally in Profil Institute, at the highest level of global science and business spheres. Both institutions will continue to combine their creative energies and community spirit to empower the diabetes patient community to participate in research and outreach initiatives.
Insulindependence (IN) is a San Diego-based 501(c)3 nonprofit public benefit corporation. Their mission is to inspire people with diabetes to set personal fitness goals, educate them on adaptive management strategies through hands-on-experience, and equip them to explore their individual capacities. IN's staff and volunteers serve thousands of U.S. program participants annually in an effort to revolutionize diabetes management through experiential diabetes education. www.insulindependence.org
Media Contact: Blair Ryan Insulindependence, Inc., 888.912.3837 Ext. 108, Blair@insulindependence.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Insulindependence, Inc.